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Abstract
Background: On-site rapid interpretation (RI) of fine needle aspiration (FNA) has been shown to
increase the diagnostic yield of FNA and decrease the need for repeat diagnostic procedures.
Because the pathologist interprets only a fraction of the sample and has limited resources available
at such times, an occasional RI diagnosis will be changed at the time of the final diagnosis. We
investigated how often these changes in diagnoses occur and the possible reasons for the changes.
Methods: All cytology reports from 1/1/02 to 12/31/03 from a single institution were reviewed.
Cases with RI with discrepant final diagnoses were noted. The discrepant diagnoses were
categorized depending on how they were changed. Possible sources for changed diagnoses were
noted.
Results: Between 1/1/02 and 12/31/03 there were 1368 RIs of FNAs. Of these 80 (5.8%) had
discrepancies between the RIs and final diagnoses. Seventy-eight cases had additional slides and/or
cell block at time of final diagnosis. 16 cases had ancillary studies available at final diagnosis.
Consultant pathologists were used in 7 cases. Different pathologists interpreted the RI and final
diagnosis in 31 cases.
Conclusion: Although uncommon, discrepancies between RIs and final diagnoses occur 5.8% of
the time at our institution. Most commonly, this involves a change of diagnosis from either "non-
diagnostic" or "benign" to "malignancy". Although much of this is likely due to the presence of
additional material and information at the time of final diagnosis, the number of cases that had
different pathologists involved in the RI and final diagnosis suggests that inter-observer variability
may also play some role.
This data was originally presented at the 2005 meeting of the United States and Canadian Academy 
of Pathology in San Antonio, Texas, March, 2005.
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Background
On-site rapid interpretation (RI) of fine needle aspiration
(FNA) has been shown to increase the diagnostic yield of
FNA and decrease the need for repeat diagnostic proce-
dures. Previous studies have shown that up to 32% of
FNAs performed without on-site rapid interpretation are
non-diagnostic [1-12]. On-site evaluation of FNA speci-
mens can be beneficial in determining adequacy, triaging
of specimens for ancillary studies as well as providing a
preliminary diagnosis to the clinicians for possible rapid
clinical decision making [12]. Because the pathologist
interprets only a fraction of the sample obtained and has
limited resources available at such times, an occasional RI
diagnosis will be changed at the time of the final diagno-
sis. Furthermore, inter-observer variability may play some
role in these changes as different pathologists may some-
times review the on-site material and the final material.
We investigated at our institution how often these
changes in interpretations occur as well as the reasons for
the changes.
Materials and methods
All cytology reports from 1/1/02 to 12/31/03 from a sin-
gle institution were reviewed for FNA cases in which an
on-site interpretation (RI) was performed. The aspirates
were performed by the clinician, radiologist or patholo-
gist. All on-site evaluations, including the preparation of
smears, rendering of preliminary diagnosis and triage of
specimen for possible ancillary studies were performed by
an attending pathologist (RHB, MWS and 2 others not
included as authors). Of these pathologists, 2 of 4 (RHB
and MWS) had subspecialty training in cytopathology. In
all cases, at least one air-dried, Diff-Quik® stained smear
was prepared for immediate microscopic evaluation.
Additional smears were fixed in alcohol and stained with
the Papanicolaou stain and reviewed at final interpreta-
tion. If additional material was available, cell blocks were
prepared by allowing material to clot, scraping it into 10%
buffered formalin and then processing the material by
routine histologic methods. Ancillary studies were sub-
mitted at the discretion of the pathologist who interpreted
the material on-site. Final interpretation included the
interpretation of all ancillary testing.
The diagnosis rendered during RI was compared to the
final diagnosis. Cases with discrepant diagnoses were cat-
egorized depending on how they were changed. Possible
sources for changed diagnoses included additional smears
and cell block, the use of ancillary techniques such as
immunohistochemistry and flow cytometry, the use of
consultant pathologists, and changes in the pathologist
on service at the time of RI versus final diagnosis. All diag-
noses (RI and Final) were categorized as either non-diag-
nostic (ND), benign non-neoplastic (BNonN), benign
neoplasm (BN), atypical/suspicious (AS) or malignant
(M).
Results
Between 1/1/02 and 12/31/03 there were 1368 RIs of
FNAs. Of the 1368 RIs, 80 (5.8%) had discrepancies
between the RIs and final diagnoses (see table 1). Of the
80 cases with discrepant RI and final diagnoses, eleven
were considered to be false positives (10 cases originally
interpreted as A/S and 1 originally interpreted as M). Spec-
imens originally deemed ND were found to be BNonN
(10), BN (3), AS (4), and M (21). Specimens deemed
BNonN were found to be a different BNonN (7), BN (2),
AS (4), and M (12). Specimens deemed BN were found to
be BNonN (2). Specimens deemed AS were found to be
BNonN (10). A single case deemed M was found to be
BNonN. Four cases deemed M were found to be different
Ms. Seventy-eight cases had additional slides and/or cell
block at time of final diagnosis. Sixteen cases had ancillary
studies available at final diagnosis. Consultant patholo-
gists were used in 7 cases. Different pathologists inter-
preted the RI and final diagnosis in 31 cases.
Discussion
The use of FNA biopsy has become an important diagnos-
tic tool for the work-up of the clinical patient. It is a highly
safe and accurate technique causing minimal discomfort,
trauma and complications to the patient. Though not uni-
formly practiced in all centers, an on-site RI of the FNA is
often performed. This has been shown to increase the
diagnostic yield of the aspirate as well as minimizing the
incidence of repeat biopsies [3-5,7,17-19]. The main indi-
cation of an on-site RI of the fine-needle aspirate is to
determine the adequacy of the specimen for definitive
evaluation, thus minimizing the unsatisfactory rate [14].
Based on the available material, a specific preliminary
diagnosis can often be rendered by the examining pathol-
ogist, guiding further clinical investigations and decisions,
as well as determining the need for further ancillary stud-
Table 1: Discrepant Diagnoses between Rapid Interpretations 
and Final Diagnoses
On-site Interpretation Final Diagnosis
Non-diagnostic (38) Benign, non-neoplastic (10)
Benign neoplasm (3)
Atypical/suspicious (4)
Malignancy (21)
Benign, non-neoplastic (25) Different benign non-neoplastic (7)
Benign neoplasm (2)
Atypical/suspicious (4)
Malignancy (12)
Benign, neoplasm (2) Benign. Non-neoplastic (2)
Atypical/suspicious (10) Benign, non-neoplastic (10)
Malignancy (5) Benign, non-neoplastic (1)
Different malignancy (4)CytoJournal 2006, 3:25 http://www.cytojournal.com/content/3/1/25
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ies including flow cytometry, microbiology cultures,
molecular studies and immunohistochemistry.
While the performance of the FNA biopsy has increased
markedly, there have only been a handful of reports look-
ing at the discrepancy rate between the RI diagnosis and
the final diagnosis. As far as we know, our study is one of
the largest of its kind with a total of 1368 cases of FNAs
with on-site RI obtained over a two year period. Interest-
ingly, a major proportion of our RIs occurred with speci-
mens obtained via endoscopic-ultrasound guided FNA.
In our study, we found that the diagnostic discordance
rate was approximately 5.8% with 80 cases for which the
RI diagnosis was different from that of the final diagnosis.
These results are similar to previously published studies
that report concordance rates ranging from 82% to 100%
[5-7,12-16]. Of the 80 cases, there were 41 false negative
diagnoses (if one includes cases originally interpreted as
non-diagnostic) and 11 false positive diagnoses giving a
false negative and false positive rate of 3.00% and 0.80%,
respectively.
Our review of all 80 RI diagnosis cases with discordant
final diagnoses suggests that the major cause of discrep-
ancy occurred secondary to sampling errors in which diag-
nostic material was not present on the originally
interpreted slides, but was present in the additional mate-
rial interpreted at sign-out (alcohol fixed slides/cell
block). This error likely accounted for the majority of false
negative diagnoses rendered in our institution (38 cases
found to be ND at RI had a diagnosis at sign out). This is
not surprising given the fact that the pathologist is only
able to examine about half of the submitted sample on-
site (at our institution), which may or may not include
adequate diagnostic material. The remainder of the sub-
mitted specimen is fixed in alcohol or prepared for cell
block and was only available for examination the next
working day. Furthermore, we believe that, in general, we
set our diagnostic threshold somewhat higher during RI,
hoping to obtain more material and thus eliminating final
unsatisfactory diagnoses. Other causes of the discrepan-
cies include the eventual availability of additional ancil-
lary studies and additional clinical history at time of final
diagnosis. Interpretive errors constituted a very small per-
centage in the cause of discrepancy during on-site RI.
These were predominately the false positive diagnoses.
Out of the 80 cases of discrepant diagnoses, we identified
only eleven false positive cases for which the RI diagnosis
was deemed atypical/suspicious (10) or malignant (1),
but was found to be benign non-neoplastic at final diag-
nosis. These errors could be considered clinically signifi-
cant as they may lead to an unnecessary surgical or
medical treatment. Because we know that these errors can
and do occur, we do try to stress the fact that RIs are pre-
liminary interpretations and that treatment should not be
instituted based on these diagnoses, especially with atypi-
cal/suspicious diagnoses.
Interestingly, at our institution, 31 of the 80 (38.8%) dis-
crepant diagnoses involved different pathologists evaluat-
ing the RI and the final diagnosis. Given the fact that our
pathologists generally rotate on a weekly schedule, this
suggests that inter-observer variability may also play some
role in contributing to the discrepant diagnosis. Further
studies need to be done to investigate the extent this factor
contributed to the incidence of discrepant diagnoses.
In conclusion, our study confirms that the diagnoses ren-
dered during RI are highly accurate and are usually con-
cordant with the final diagnoses. However, our study
shows a 5.8% discrepancy rate between RIs and final diag-
noses. With this in mind, pathologists should communi-
cate to clinicians the limitations of the RI, and clinicians
should in turn delay any unnecessary critical decisions
regarding therapy until the final diagnosis becomes avail-
able.
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